Device Trial Radar · NCT03863132
accuRate Evaluation of Benefit With Optimal Medical Treatment With or Without Transcatheter Valve Repair of PARADOXical Low Flow Low Gradient Aortic Stenosis
Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
120
Actual
Start
Jul 3, 2019
Primary completion
Sep 1, 2027
Study completion Sep 1, 2027
Sponsor
- Lead sponsor
- IHF GmbH - Institut für HerzinfarktforschungAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Boston Scientific Corporation; Yale University
- First posted
- Mar 5, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Aim of this study is to evaluate whether microsurgical repair or replacement of the aortic valve is a treatment option for a subgroup of patients suffering from aortic Stenosis.
Conditions
- Aortic Valve Stenosis
Interventions
TAVRDevice
Repair of defective aortic valve by microsurgical Intervention.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to deathTime frame: 24 months after last-patient-in
Locations
15 sites in 3 countries. Site status is shown where the registry gives one.
Universitätsklinikum Tübingen
Tübingen, Baden-Wurttemberg, Germany
Deutsches Herzzentrum München
München, Bavaria, Germany
Klinikum der Universität München-Großhadern
München, Bavaria, Germany
12 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.